- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | SciBase: Nevisense (EIS) included in updated German (S1) imaging guidelines | 157 | PR Newswire | STOCKHOLM, Sweden, Jan. 23, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today... ► Artikel lesen | |
| Do | SCIBASE: Nevisense (EIS) included in updated German (S1) imaging guidelines. | 2 | Cision News | ||
| 14.01. | SciBase announces final outcome of directed issue and rights issue | 271 | PR Newswire | STOCKHOLM, Jan. 14, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase" or the "Company") today announces the final outcome of the capital raise, consisting of a rights issue of units of approximately... ► Artikel lesen | |
| SCIBASE Aktie jetzt für 0€ handeln | |||||
| 13.01. | SciBase announces outcome of directed issue and preliminary outcome of rights issue | 251 | PR Newswire | STOCKHOLM, Jan. 13, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase" or the "Company") today announces the preliminary outcome of the capital raise, consisting of a rights issue of units... ► Artikel lesen | |
| 03.01. | SciBase: The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot | 307 | PR Newswire | STOCKHOLM, Jan. 3, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that... ► Artikel lesen | |
| 27.12.24 | Today the subscription period in SciBase rights issue begins | 442 | PR Newswire | STOCKHOLM, Dec. 27, 2024 /PRNewswire/ -- Today, on December 27, 2024, is the first day of the subscription period in SciBase Holding AB's ("SciBase" or the "Company") rights issue of units... ► Artikel lesen | |
| 20.12.24 | SciBase letter from the CEO | 338 | PR Newswire | STOCKHOLM, Dec. 20, 2024 /PRNewswire/ -- In 2024, SciBase has advanced its positions significantly and laid the foundation for continued growth, with a new organization in the US, success... ► Artikel lesen | |
| 20.12.24 | SciBase publishes prospectus | 342 | PR Newswire | STOCKHOLM, Dec. 20, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase" or the "Company") announced on November 12, 2024 that the Board of Directors has resolved, subject to the subsequent... ► Artikel lesen | |
| 18.12.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 18.12.2024 | 280 | Xetra Newsboard | Das Instrument 087 GB00BD7XPJ64 NEWRIVER REIT LS-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 18.12.2024 und ex Kapitalmassnahme am 19.12.2024 The instrument 087 GB00BD7XPJ64 NEWRIVER REIT LS-... ► Artikel lesen | |
| 13.12.24 | Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) | 323 | PR Newswire | STOCKHOLM, Dec. 13, 2024 /PRNewswire/ -- Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance... ► Artikel lesen | |
| 13.11.24 | SciBase Announces Positive Findings in Case Study Monitoring Treatment Outcomes in Atopic Dermatitis Patient | 393 | PR Newswire | STOCKHOLM, Nov. 13, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of artificial intelligence (AI)-based solutions for skin is excited to announce the... ► Artikel lesen | |
| 12.11.24 | Notice to extraordinary general meeting in Scibase Holding AB (publ) | 261 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- Shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby summoned to an extraordinary general meeting to be held... ► Artikel lesen | |
| 12.11.24 | SciBase announces collaboration for prediction of atopic dermatitis in infants | 332 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today its... ► Artikel lesen | |
| 12.11.24 | SciBase decides on a directed issue of approximately SEK 22.5 million and a rights issue of up to approximately SEK 59.3 million | 450 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today decided to carry out a capital raise totaling approximately... ► Artikel lesen | |
| 12.11.24 | SciBase: Interim report January 1 - September 30, 2024 | 263 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- January 1 - September 30, 2024
The third quarter in figures
Net sales were TSEK 8,408 (7,248), +16%.The loss after tax was TSEK 17,753... ► Artikel lesen | |
| 30.10.24 | SciBase initiates sales collaboration in Italy | 202 | PR Newswire | STOCKHOLM, Oct. 30, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announces today the collaboration... ► Artikel lesen | |
| 21.10.24 | SciBase continues US expansion and will attend Fall Clinical conference | 322 | PR Newswire | STOCKHOLM, Oct. 21, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders will attend a leading... ► Artikel lesen | |
| 14.10.24 | Nomination Committee appointed for SciBase Holding's Annual General Meeting in 2025 | 349 | PR Newswire | STOCKHOLM, Oct. 14, 2024 /PRNewswire/ -- The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2025:
Anders... ► Artikel lesen | |
| 27.09.24 | SciBase announces sale of Nevisense to NIH (US) | 251 | PR Newswire | STOCKHOLM, Sept. 27, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO: SCIB], pioneering prevention and prediction in dermatology disorders is pleased to announce the completion of... ► Artikel lesen | |
| 26.09.24 | SciBase expands to new market in Pennsylvania and receives first order from large dermatology practice | 334 | PR Newswire | STOCKHOLM, Sept. 26, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), pioneering prevention and prediction in dermatology announces today a partnership with Seraly Dermatology... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
57 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 80,61 | +5,46 % | Roku Stock Sees RS Rating Climb To 79 | ||
| SERNOVA | 0,134 | -0,89 % | Sernova (TSE:SVA) Sets New 12-Month Low - Here's What Happened | ||
| BOSTON SCIENTIFIC | 98,00 | +1,55 % | Minimales Kursplus bei der Boston Scientific-Aktie (96,0998 €) | Der Kurs der dem Anteilsschein von Boston Scientific kommt kaum von der Stelle. Zuletzt zahlten Investoren für das Papier 98,73 US-Dollar. Der Kurs der Aktie von Boston Scientific zeigt sich gegenwärtig... ► Artikel lesen | |
| PAUL HARTMANN | 224,00 | -0,88 % | Paul Hartmann: Jedes Quartal die Prognose erhöht | Mit Aktien von Medizintechnikunternehmen war auch 2024 kaum etwas zu verdienen. Bekannte Titel wie Carl Zeiss Meditec, Stratec und Sartorius sorgten in den vergangenen zwölf Monaten sogar für herbe... ► Artikel lesen | |
| ADDLIFE | 12,470 | +1,14 % | AddLife AB: Interim Report 1 January - 30 September 2024 | Organic growth and stable margin while profitability improvement initiatives are progressing
"Continued organic growth and stable margin in the third quarter - a quarter that is normally somewhat weaker... ► Artikel lesen | |
| EMBECTA | 18,000 | 0,00 % | Embecta Corp.: embecta to Report Fiscal First Quarter 2025 Financial Results | ||
| SYSMEX | 18,800 | 0,00 % | Dividendenbekanntmachungen (27.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN EUROPEAN LOGISTICS INCOME PLC GB00BD9PXH49 0,0077 GBP EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1926 EUR ACOM CO LTD JP3108600002 7... ► Artikel lesen | |
| R1 RCM | 13,400 | 0,00 % | R1 RCM Inc. (RCM): Driving Strong Revenue Growth with AI-Driven Solutions and Strategic Partnerships in Healthcare | ||
| ENOVIS | 45,000 | -1,75 % | Enovis Corporation: Enovis Announces Leadership Change to International Surgical Business | Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin... ► Artikel lesen | |
| PULMONX | 5,850 | 0,00 % | Pulmonx Corp - 10-Q, Quarterly Report | ||
| KANGJI MEDICAL | 0,735 | +0,68 % | KANGJI MEDICAL (09997): NEXT DAY DISCLOSURE RETURN | ||
| KOOTH | 2,020 | 0,00 % | TRADING UPDATES: Kooth eyes top-end profit, while IQE sees sales beat | ||
| SI-BONE | 16,200 | +1,25 % | SI-BONE, Inc.: SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024 | Fourth Quarter 2024 worldwide revenue of ~$48.8 to $49.0 million representing growth of ~26%Achieved adjusted EBITDA profitability in the fourth quarter SANTA CLARA, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| PEIJIA MEDICAL | 0,444 | -5,93 % | Peijia Medical Announces 2024 Interim Results | HONG KONG, Aug. 26, 2024 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutics and neurovascular interventions markets... ► Artikel lesen | |
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | 0,00 % | Revitalist Lifestyle & Wellness Ltd: Revitalist Releases Benefits Program Giving Access To All for Ketamine Therapies Changing the Narrative of Mental Health to Risk Mitigation | Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) (the "Company") announces release of a benefits plan to... ► Artikel lesen |
SCIBASE HOLDING AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,008 (+82,00 %) liegt der Kurs bei 0,018 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCIBASE HOLDING AB finden Sie auf Wallstreet Online.
